VX-950 and Peginterferon for Hepatitis C

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2005

Study Completion Date

March 31, 2006

Conditions

Hepatitis C

Interventions

DRUG

VX-950

DRUG

peginterferon

Trial Locations (2)

Call for information, Homburg/Saar

Call for information, Amsterdam

All Listed Sponsors

lead

Vertex Pharmaceuticals Incorporated

INDUSTRY

NCT00251199 - VX-950 and Peginterferon for Hepatitis C | Biotech Hunter | Biotech Hunter